NCT03379129 (FIDDS) is a clinical trial in Delirium, sponsored by University of Calgary.

Who is sponsoring NCT03379129?

NCT03379129 is sponsored by University of Calgary.

Is NCT03379129 still recruiting?

NCT03379129 is currently completed. Last updated 16 May 2019.

Last reviewed 2019-05-16 · How we verify

NCT03379129: FIDDS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Family ICU Delirium Detection Study

Completed Last updated 16 May 2019

What this trial tests

trial in Delirium in 147 participants. Completed in 14 September 2018.

Timeline

6 November 2017

Primary endpoint
14 September 2018

14 September 2018

Quick facts

Lead sponsor	University of Calgary
Status	Completed
Study type	OBSERVATIONAL
Enrollment	147
Start date	6 November 2017
Primary completion	14 September 2018
Estimated completion	14 September 2018
Sites	1 location across Canada

Conditions studied

Delirium — all drugs for Delirium →

Sponsor

University of Calgary

Who can join

18 and older, any sex, with Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the validity, reliability, and acceptability of employing family-administered delirium detection tools in the critically ill. The ultimate goal of this project is to improve the care of critically ill patients by creating valid, earlier, and patient and family-centered prevention, recognition, and management of delirium.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Feasibility and acceptability of family administration of delirium detection tools in the intensive care unit: a patient-oriented pilot study.
Krewulak KD, Sept BG, Stelfox HT, Ely EW, et al · · 2019 · cited 36× · PMID 31028053 · DOI 10.9778/cmajo.20180123
Adaptation and Validation of a Chart-Based Delirium Detection Tool for the ICU (CHART-DEL-ICU).
Krewulak KD, Hiploylee C, Ely EW, Stelfox HT, et al · · 2021 · cited 35× · PMID 33348428 · DOI 10.1111/jgs.16987
Associations between caregiver-detected delirium and symptoms of depression and anxiety in family caregivers of critically ill patients: a cross-sectional study.
Rosgen BK, Krewulak KD, Davidson JE, Ely EW, et al · · 2021 · cited 15× · PMID 33836699 · DOI 10.1186/s12888-021-03200-7
Patients, family members and providers perceive family-administered delirium detection tools in the adult ICU as feasible and of value to patient care and family member coping: a qualitative focus group study.
Parsons Leigh J, Krewulak KD, Zepeda N, Farrier CE, et al · · 2021 · cited 11× · PMID 33210217 · DOI 10.1007/s12630-020-01866-3
The impact of patient delirium in the intensive care unit: patterns of anxiety symptoms in family caregivers.
Poulin TG, Krewulak KD, Rosgen BK, Stelfox HT, et al · · 2021 · cited 8× · PMID 34740349 · DOI 10.1186/s12913-021-07218-1

Verify or expand the search:

Other recruiting trials for Delirium

Currently open trials in the same condition.

NCT07348471 — Fecal Microbiota Transplantation for the Treatment of ICU Delirium · NA · recruiting
NCT06969287 — Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery · Phase 3 · recruiting
NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
NCT07488468 — Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures · recruiting
NCT07136207 — Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients · recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03379129 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 16 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03379129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing